-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$315.75-4.65% Downside
Recent Analyst Forecasts and Stock Ratings
Madrigal Pharmaceuticals, Inc. Frequently Asked Questions
-
What analysts cover Madrigal Pharmaceuticals, Inc.?
Madrigal Pharmaceuticals, Inc. has been rated by research analysts at Piper Sandler, H.C. Wainwright, Evercore ISI, UBS, Jefferies, JMP Securities in the past 90 days.